Cold Form Blister Foil Market: By Material Type (Oriented-Polyamide, Aluminum, PVC, PP, PE, PET, and Others), By Application (Pharmaceuticals, Consumer Goods, Food and Confectionary, Industrial Applications, and Others), and Geography

Cold Form Blister Foil Market size was valued at USD 4,829.3 Million in 2023 and is poised to grow at a CAGR of 5.7% from 2024-2030. The cold form blister foil market refers to the commercial landscape associated with the production, distribution, and utilization of cold form blister foils as a specialized packaging material primarily used in the pharmaceutical and healthcare industries. Cold form blister foils are composed of a laminate of aluminum and plastic layers that provide exceptional protection to pharmaceutical products, such as tablets, and capsules, ensuring their integrity, stability, and safety. The expansion of the pharmaceutical and healthcare sectors is a primary driver for the Cold Form Blister Foil market. As these industries develop and diversify, the demand for secure and protective packaging solutions, such as cold form blister foils, increases to ensure product integrity and patient safety.

Increasing focus on advancing barrier properties of the cold form blister foil also contribute the market growth. Innovations in material science and technology could lead to the development of cold form blister foils with enhanced barrier properties. Foils that offer even greater protection against moisture, oxygen, and light would be highly sought after in the pharmaceutical industry. However, adhering to the stringent regulations governing pharmaceutical packaging can be demanding. Meeting varying regulatory standards across different regions can pose challenges for manufacturers operating in multiple markets. Meanwhile, cold form blister foils that allow for improved printing capabilities, vivid colors, and intricate designs offer branding chances for pharmaceutical companies, which creates potential prospects for the cold form blister foil market. Key manufacturers are announcing acquisitions and collaborating with pharmaceutical companies to design packaging solutions tailored to specific medications that can create value-added partnerships that cater to unique product requirements. For example, in April 2023, Gualapack acquired Print & Packaging Farma’s activities through its subsidiary Gualapack Pharma S.r.l. to increase its product portfolio.

Cold Form Blister Foil Market Key Developments:

• In July 2023, Constantia Flexibles launched its ‘total barrier’, designed-for-recycling coldform foil solution, REGULA CIRC, to withstand delamination and prevent the product within from becoming contaminated.
• In September 2018, PCI Pharma Services (PCI) collaborated with CSP Technologies, Inc. for breakthrough activ-blister tm solutions.
• In August 25, 2020, Oliver Healthcare Packaging acquires Kansas City Design, forms new premium design business serving the Pharmaceutical and Biologics Market